Cleared Special

MAMMOVISTA B.smart (VB70) (K223363) - FDA 510(k) Clearance

Class II Radiology device cleared through the Special 510(k) pathway - typically does not require clinical trials.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2023
Decision
70d
Days
Class 2
Risk

K223363 is an FDA 510(k) clearance for the MAMMOVISTA B.smart (VB70). Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Siemens Medical Solutions USA, Inc. (Malvern, US). The FDA issued a Cleared decision on January 12, 2023 after a review of 70 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Incremental AI imaging tool. Low regulatory complexity profile. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Siemens Medical Solutions USA, Inc. devices

Submission Details

510(k) Number K223363 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 03, 2022
Decision Date January 12, 2023
Days to Decision 70 days
Submission Type Special
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
37d faster than avg
Panel avg: 107d · This submission: 70d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 819
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K223363.
MIM – Additional Tracers
K223800 · Mim Software, Inc. · Jan 2023
MR Diffusion Perfusion Mismatch V1.0
K223502 · Olea Medical · Jan 2023
AIBOLIT 3D+
K222458 · Aibolit Technologies, LLC · Jan 2023
Vitrea Software Package, VSTP-002A
K223336 · Canon Medical Systems Corporation · Jan 2023
TECHFIT Diagnostic Models
K222577 · Techfit Digital Surgery, Inc. · Jan 2023
OnyxCeph
K213263 · Image Instruments GmbH · Jan 2023